These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8138907)

  • 1. Pharmacokinetics of multiparticulate sustained-release diltiazem preparations in dogs.
    Murata K; Noda K
    J Pharm Sci; 1994 Jan; 83(1):38-41. PubMed ID: 8138907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of an oral sustained-release diltiazem preparation.
    Murata K; Yamahara H; Kobayashi M; Noda K; Samejima M
    J Pharm Sci; 1989 Nov; 78(11):960-3. PubMed ID: 2621582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic analysis of an oral sustained-release diltiazem preparation using multifraction absorption models.
    Murata K; Noda K
    Pharm Res; 1993 May; 10(5):757-62. PubMed ID: 8321842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of diltiazem and its metabolites in dogs after oral administration of a multiparticulate sustained-release preparation.
    Murata K; Yamahara H; Noda K
    Pharm Res; 1993 Aug; 10(8):1165-8. PubMed ID: 8415402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic analysis of two new sustained-release products of diltiazem designed for twice- and once-daily treatment.
    Bialer M; Hadad S; Golomb G; Barel S; Samara E; Abu Salach O; Berkman N; Danenberg HD; Ben David J; Caron D
    Biopharm Drug Dispos; 1994 Jan; 15(1):45-52. PubMed ID: 8161715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and in vitro-in vivo evaluation of a multiparticulate sustained release formulation of diltiazem.
    Li SP; Felt RG; Di Paolo LC; Huang MY; Williams RO
    Pharm Res; 1995 Sep; 12(9):1338-42. PubMed ID: 8570532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Criteria to assess in vivo performance of sustained release products: application to diltiazem formulations.
    Bialer M; Sussan S; Abu Salach O; Danenberg HD; Ben-David J; Gibor Y; Laor A
    J Pharm Sci; 1995 Oct; 84(10):1160-3. PubMed ID: 8801328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel orally swallowable IntelliCap(®) device to quantify regional drug absorption in human GI tract using diltiazem as model drug.
    Becker D; Zhang J; Heimbach T; Penland RC; Wanke C; Shimizu J; Kulmatycki K
    AAPS PharmSciTech; 2014 Dec; 15(6):1490-7. PubMed ID: 25023947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of diltiazem tablet and multiparticulate osmotic formulations in the dog.
    Sutton SC; Engle K; Deeken RA; Plute KE; Shaffer RD
    Pharm Res; 1990 Aug; 7(8):874-8. PubMed ID: 2235885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of concomitant colestipol hydrochloride administration on the bioavailability of diltiazem from immediate- and sustained-release formulations.
    Turner SW; Jungbluth GL; Knuth DW
    Biopharm Drug Dispos; 2002 Dec; 23(9):369-77. PubMed ID: 12469330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of food on the bioavailability of diltiazem and two of its metabolites following the administration of conventional tablets and slow-release capsules.
    Du Souich P; Lery N; Lery L; Varin F; Boucher S; Vezina M; Pilon D; Spenard J; Caillé G
    Biopharm Drug Dispos; 1990 Mar; 11(2):137-47. PubMed ID: 2328299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo performance of controlled release pellets of diltiazem HCl.
    Nisarur-ur-Rahman ; K H Y; Jia Woei W
    Pak J Pharm Sci; 2005 Apr; 18(2):44-8. PubMed ID: 16431398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on pulsatile release tablets of diltiazem hydrochloride in explosion way].
    Fan TY; Wei SL; Yan WW; Ding WX
    Yao Xue Xue Bao; 2002 Mar; 37(3):221-5. PubMed ID: 12579768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption of diltiazem in beagle dog from pulsatile release tablet.
    Ishino R; Yoshino H; Hirakawa Y; Noda K
    Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3094-6. PubMed ID: 1477926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and bioavailability of diltiazem sustained-release: influence of food and time of administration.
    Bianchetti G; Bagheri H; Houin G; Dubruc C; Thénot JP
    Fundam Clin Pharmacol; 1995; 9(2):197-201. PubMed ID: 7628834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The solubility-modulated osmotic pump: in vitro/in vivo release of diltiazem hydrochloride.
    McClelland GA; Sutton SC; Engle K; Zentner GM
    Pharm Res; 1991 Jan; 8(1):88-92. PubMed ID: 2014214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-carboxymethyl-O-ethylcyclomaltoheptaose as a delayed-release-type drug carrier: improvement of the oral bioavailability of diltiazem in the dog.
    Uekama K; Horiuchi Y; Irie T; Hirayama F
    Carbohydr Res; 1989 Oct; 192():323-30. PubMed ID: 2611776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow-release characteristics of diltiazem from ethylated beta-cyclodextrin complexes.
    Horiuchi Y; Hirayama F; Uekama K
    J Pharm Sci; 1990 Feb; 79(2):128-32. PubMed ID: 2324960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro/in vivo correlation of prolonged release dosage forms containing diltiazem HCI.
    Caramella C; Ferrari F; Bonferoni MC; Sangalli ME; De Bernardi di Valserra M; Feletti F; Galmozzi MR
    Biopharm Drug Dispos; 1993 Mar; 14(2):143-60. PubMed ID: 8453024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and pharmacokinetics of a new sustained-release formulation of diltiazem.
    Thiercelin JF; Necciari J; Caplain H; Cournot A; Combes M; Desmolin H; Flouvat B
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S31-7. PubMed ID: 1706011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.